title: Prevention and control of influenza recommendations of the Advisory Committee on Immunization Practices (ACIP). Centers for Disease Control and Prevention.
abstract: These recommendations update information on the vaccine and antiviral agents available for controlling influenza during the 1995-96 influenza season (superseding MMWR 1994;43(No. RR-9) 1-13 and MMWR 1994;43(No. RR-15): 1-10). The principal changes include information about a) the influenza virus strains included in the trivalent vaccine for 1995-96, b) side effects and adverse reactions, and c) the vaccination of pregnant women.
mesh_terms: D000547:Amantadine / Q000627:therapeutic use; D000998:Antiviral Agents / Q000627:therapeutic use; D006801:Humans; D007115:Immunization Schedule; D009980:Influenza A virus / Q000276:immunology; D009981:Influenza B virus / Q000276:immunology; D007252:Influenza Vaccines / Q000008:administration & dosage* / Q000009:adverse effects / Q000276:immunology; D007251:Influenza, Human / Q000188:drug therapy / Q000517:prevention & control*; D012299:Rimantadine / Q000627:therapeutic use; D015164:Vaccines, Inactivated
chemical_list: D000998:Antiviral Agents; D007252:Influenza Vaccines; D015164:Vaccines, Inactivated; D012299:Rimantadine; D000547:Amantadine